Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

In losing weight, Oprah Winfrey gained a new perspective ... she began using weight loss medications. In fact, Oprah recently detailed the ways in which using the drugs altered the way she ...

Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight ...

Novo Nordisk's stock (NVO) rose more than 8% in Friday trading on news that the company's latest weight-loss product delivered favorable results. The new drug, amycretin, similar to the company's ...

It turned out she was right. Dr Cecil later learned her new non-profit insurance plan could not afford to cover the cost of the drugs. She gradually gained back most of the weight she lost. The latest ...

Novo Nordisk scored a much-needed win on Friday, with early-stage data on a new weight-loss drug that suggested it could work better than the obesity blockbusters already on the market.

The soaring demand for antidiabetic and weight-loss drugs has lured in many biotech and big Pharma companies. Onto this crowded field comes a new player ... approval in 2022; the company filed ...

“I never have used weight loss drugs to ... getting healthy.” New Mom Gypsy-Rose Blanchard Shows Off Postpartum Body ‘Almost a Week’ After Giving Birth GLP-1 drugs — including Ozempic ...